The self-replicating nanobot Kurzweil feared was never built. But his argument about it — a determined adversary defeats any centralized safeguard — just came true in a biosecurity lab, with a number attached.
Six approved siRNA drugs and zero of them treat infection or cancer. The COVID lab tested every prediction in Kurzweil’s biosecurity chapter, and the molecule he championed won the wrong race.